12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several healthcare stocks experienced significant movements. Syra Health (SYRA) led the gainers with a 21.2% increase, while Synaptogenix (SNPX) saw the largest decline among the losers with an 8.5% drop. Other notable movers included Universe Pharmaceuticals (UPC), MaxCyte (MXCT), Elevation Oncology (ELEV), and BrainsWay (BWAY) with gains, and OKYO Pharma (OKYO), LumiraDx (LMDX), Soligenix (SNGX), 180 Life Sciences (ATNF), and Vigil Neuroscience (VIGL) with losses.
January 08, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
180 Life Sciences stock declined by 5.14% to $0.19, with a market cap of $1.8 million.
The after-market loss for 180 Life Sciences could suggest a lack of investor confidence, potentially leading to further short-term declines.
CONFIDENCE 70
IMPORTANCE 55
RELEVANCE 75
NEGATIVE IMPACT
LumiraDx shares dropped by 7.5% to $0.01, with a market cap of $4.7 million.
LumiraDx's significant after-market drop could indicate a negative outlook, potentially leading to further short-term losses.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 85
NEGATIVE IMPACT
OKYO Pharma stock decreased by 7.81% to $1.74, with a market cap of $57.9 million.
The drop in OKYO Pharma's stock price suggests potential bearish sentiment that could negatively affect the stock in the near term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Soligenix stock fell by 5.2% to $0.89, with a market cap of $9.2 million.
The decline in Soligenix's stock price may continue if the negative sentiment persists in the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Synaptogenix shares fell by 8.5% to $0.23, with a market cap of $4.6 million.
The decline in Synaptogenix's stock price could reflect negative sentiment, which might lead to further short-term depreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Vigil Neuroscience stock decreased by 4.96% to $3.45, with a market cap of $123.7 million.
Vigil Neuroscience's stock price drop could reflect short-term bearish sentiment, potentially leading to more declines.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
BrainsWay stock rose by 5.62% to $7.51, with a market cap of $124.8 million.
The increase in BrainsWay's stock price may indicate a bullish sentiment that could positively impact the stock in the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 75
POSITIVE IMPACT
Elevation Oncology's shares went up by 7.73% to $1.95, with a market cap of $82.7 million.
Elevation Oncology's stock increase could suggest investor confidence, potentially leading to more short-term gains.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 80
POSITIVE IMPACT
MaxCyte shares increased by 10.23% to $5.06, with a market cap of $524.0 million.
MaxCyte's after-market rise indicates positive momentum that could carry into the short-term trading sessions.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Syra Health's stock rose 21.2% to $1.5, with a market cap of $9.6 million.
The significant after-market gain for Syra Health suggests positive investor sentiment which could lead to a short-term continuation of this upward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Universe Pharmaceuticals' stock increased by 13.15% to $2.58, with a market cap of $9.3 million.
The notable rise in Universe Pharmaceuticals' stock price could attract more attention, potentially leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90